Highlights of the BMC Series – December 2022
Does the discovery of a neoplasm in a Triassic amphibian complement our knowledge about the origin of cancer? Is there a link between creativity and scientific… Read more »
Anastasia joined BMC in May 2022. She holds a PhD in Medicine from University of Leeds where she studied the role of DOCK4 in glioblastoma, and the pathological effects of radiotherapy on the vasculature of recurrent glioblastoma. Previously, she earned her BSc (Hons) degree in Biomedical Sciences from the University of Brighton. In 2016, Anastasia worked at the Eijkman Institute of Molecular Biology in Jakarta, Indonesia, studying the genetics of obesity. She is committed to championing open access and reproducible research in science.
Anastasia is based in the London office and is the editor of BMC Medical Ethics, BMC Complementary Medicine and Therapies, BMC Pharmacology and Toxicology, and BMC Proceedings.
Anastasia is based in the London office and is the editor of BMC Medical Ethics, BMC Complementary Medicine and Therapies, BMC Pharmacology and Toxicology, and BMC Proceedings.
Latest posts by Anastasia Widyadari (see all)
- Highlights of the BMC Series – December 2022 - 27th January 2023
- BMC Pharmacology and Toxicology attends the American Association of Pharmaceutical Scientists PharmSci 360 Meeting 2022 - 17th November 2022
- Highlights of the BMC Series – August 2022 - 28th September 2022
BMC Pharmacology and Toxicology attends the American Association of Pharmaceutical Scientists PharmSci 360 Meeting 2022
This autumn, BMC Pharmacology and Toxicology flew to Boston, Massachusetts to attend the AAPS PharmSci 360 2022 Meeting. Boasting over 4,100+ attendees, 550… Read more »
Highlights of the BMC Series – August 2022
Is there a link between population decline of rodents with anthropogenic disturbance and climate warming? What are the mechanisms involved in cellular apoptotic… Read more »